Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Diabetes Mellitus, Insulin-Dependent, 12
×
durvalumab
×
Clear all
Filters
3
NCT03084471
2022-12-22
STRONG
AstraZeneca
Phase 3
Completed
867 enrolled
10 charts